Selenium-responsive myopathy, also known as white muscle disease (WMD) or nutritional myodegeneration (NMD), is a degenerative muscle disease caused by deficiency of selenium and/or vitamin E.
Overview and Clinical Importance
Selenium-responsive myopathy, also known as white muscle disease (WMD) or nutritional myodegeneration (NMD), is a degenerative muscle disease caused by deficiency of selenium and/or vitamin E. This condition affects both skeletal and cardiac muscle and is clinically significant in camelids (llamas, alpacas, dromedary and Bactrian camels) and cervids (deer, elk, moose). Understanding this disease is critical for the NAVLE as it tests knowledge of pathophysiology, clinical recognition, species-specific considerations, and management in exotic and production animal species.
Although overt myopathy is rare in South American camelids compared to other livestock, selenium deficiency remains a disease of concern in many regions of North America, Europe, Australia, and New Zealand. Cervids, particularly farmed deer and elk, are susceptible to WMD, especially in selenium-deficient geographic regions.
| Risk Factor |
Clinical Relevance |
| Se-Deficient Soils |
Pacific Northwest, Great Lakes, Northeast US, Eastern Seaboard, parts of Europe, Australia, New Zealand. Soil less than 0.5 mg Se/kg is deficient. |
| Volcanic Soils |
Soils from volcanic origin (less than 10,000 years old) contain minimal selenium. Common in Pacific Northwest. |
| Acidic Soils |
Low pH reduces selenium availability and plant uptake. More humid regions have more acidic soils. |
| Feed Storage |
Vitamin E degrades up to 50% per month in stored hay. Silage, grains, and root crops are poor vitamin E sources. |
| Sulfur Interference |
High dietary sulfur (greater than 2000 ppm) and sulfur fertilizers inhibit selenium absorption in both plants and animals. |
| High PUFA Diets |
Polyunsaturated fatty acids increase vitamin E requirements by overwhelming antioxidant capacity. |
Etiology and Pathophysiology
Role of Selenium and Vitamin E
Selenium is an essential trace element that functions as an integral component of the enzyme glutathione peroxidase (GPx). This selenoenzyme catalyzes the reduction of hydrogen peroxide and lipid hydroperoxides to water and alcohols, respectively, using glutathione (GSH) as a cofactor. The main reaction is: 2GSH + H?O? → GSSG + 2H?O.
Vitamin E (alpha-tocopherol) is a lipid-soluble antioxidant that functions as a free radical scavenger within cell membranes. It protects polyunsaturated fatty acids (PUFAs) in membrane phospholipids from peroxidation by reactive oxygen species (ROS).
High-YieldSelenium and vitamin E have complementary but distinct antioxidant mechanisms. Selenium (via GPx) works intracellularly to neutralize peroxides before they damage membranes, while vitamin E works within the membrane to break free radical chain reactions. They do not replace each other but provide overlapping protection.
Mechanism of Muscle Damage
When selenium or vitamin E is deficient, reactive oxygen species accumulate and cause oxidative damage to cell membranes through lipid peroxidation. Muscle cells are particularly vulnerable because they have high metabolic activity, generate significant ROS during contraction, and contain high concentrations of calcium stored in the sarcoplasmic reticulum. The sequence of events includes increased sarcolemmal permeability, calcium influx into myocytes, activation of calcium-dependent proteases, mitochondrial dysfunction, and ultimately myocyte necrosis and calcification.
Geographic and Dietary Risk Factors
| Parameter |
Deficient |
Adequate |
| Whole Blood Se (Llama/Alpaca) |
Less than 120 ng/mL |
150-220 ng/mL |
| Serum Se (Alpaca) |
Less than 80 ng/mL |
Greater than 0.5-0.7 μmol/L |
| Serum Se (Llama) |
Less than 110 ng/mL |
203-213 ng/mL |
| Hepatic Se |
Less than 0.4 mcg/g dry weight |
1.0-2.5 mcg/g dry weight |
| Daily Se Requirement |
N/A |
0.74-1.0 mg/day oral |
Species-Specific Considerations
Camelidae (Llamas and Alpacas)
South American camelids have unique selenium metabolism compared to ruminants. Llamas and alpacas have greater selenium-dependent glutathione peroxidase activity in serum, resulting in less difference between serum and whole blood selenium concentrations compared to cattle, sheep, and goats. This is clinically important when interpreting diagnostic values.
Camelid Selenium Status Parameters
NAVLE TipCamelids require 10 times the selenium levels of sheep or cattle. Alpacas should have 10-20 ppm selenium in the total feeding program and may become toxic at 60 ppm. FDA limits selenium supplementation in feed to 0.3 ppm (DM basis). Do NOT inject alpacas with sodium selenite or sodium selenate as rapid absorption can cause acute liver failure and death within 24 hours. Use barium selenate (depot formulation) for injectable supplementation.
Cervidae (Deer and Elk)
White muscle disease in cervids, particularly red deer (Cervus elaphus) and elk (Cervus canadensis), is well-documented and can be fatal, especially in neonates. Congenital WMD occurs when pregnant dams are selenium-deficient, resulting in fetal/neonatal myodegeneration. White-tailed deer, mule deer, and moose are also susceptible. Selenium deficiency can lead to reduced fecundity, juvenile survival rates, and population growth in wild cervid populations.
| Feature |
Cardiac Form (Peracute) |
Skeletal Form (Subacute) |
| Age Affected |
Neonates, 2-3 days of age |
Young growing animals, 1-4 weeks and older |
| Onset |
Sudden death, cardiovascular collapse within hours |
Progressive over days to weeks |
| Clinical Signs |
Recumbency, tachypnea, dyspnea, cardiac arrhythmias, pulmonary edema, weak pulse |
Stiffness, weakness, reluctance to move, arched back, muscle trembling, dysphagia |
| Muscles Affected |
Myocardium (especially left ventricle), intercostals, diaphragm |
Postural muscles: gluteals, semimembranosus, semitendinosus, tongue, neck |
| Prognosis |
Poor to grave; often fatal |
Fair to good with treatment |
| Response to Tx |
Usually ineffective |
Favorable within 24 hours if treated early |
Clinical Presentation
Forms of White Muscle Disease
WMD presents in two main clinical forms: cardiac (peracute) and skeletal (subacute). These may occur independently or concurrently.
Species-Specific Clinical Presentations
Camelids: Typically, both hind legs are symmetrically affected. Tongue and heart muscles are commonly involved in neonates. Newborns with tongue lesions have difficulty nursing and may present as "dummy" crias. Ill-thrift, infertility, neuropathy, and immunodeficiency syndromes may be associated with subclinical deficiency. Skeletal muscle swelling and pain upon walking, inability to stand, and trembling when held upright are characteristic.
Cervids: Congenital WMD in deer calves often presents at birth with weakness and inability to nurse. Sudden death during exercise is common if cardiac muscle is involved. Capture myopathy in deer shares pathophysiologic similarities with WMD and may be exacerbated by selenium deficiency. Clinical signs include depression, muscle stiffness, tremors, tachypnea, tachycardia, dark-red urine (myoglobinuria), and metabolic acidosis.
| Test |
Finding in WMD |
Clinical Significance |
| Creatine Kinase (CK) |
Markedly elevated (often greater than 100x normal) |
Most sensitive indicator of acute myonecrosis; peaks early, short half-life (hours) |
| AST |
Elevated |
Longer half-life; remains elevated after CK normalizes; also from liver |
| LDH |
Elevated |
Less specific; multiple tissue sources |
| Glutathione Peroxidase (GSH-Px) |
Decreased activity |
Highly correlated with blood selenium; used as functional biomarker |
| Whole Blood Selenium |
Less than 0.04 ppm (diseased); less than 0.1 ppm (deficient) |
Definitive diagnosis; submit heparinized blood chilled |
| Serum Vitamin E |
Less than 1.1-2 ppm (deficient) |
Deteriorates rapidly; protect from light, freeze if delayed |
| Cardiac Troponin |
Elevated with cardiac involvement |
Specific for myocardial damage |
| Urinalysis |
Myoglobinuria (dark red-brown urine) |
Indicates significant rhabdomyolysis |
Diagnosis
Clinical Pathology
Exam Focus: In polyphasic (ongoing) muscle injury like WMD, both CK and AST are persistently elevated. In monophasic (single insult) injury, CK may normalize while AST remains elevated if samples are taken more than 24 hours post-injury. This pattern helps differentiate nutritional myopathy (polyphasic) from single-event trauma or ionophore toxicity (monophasic).
Gross and Histopathologic Findings
Gross Pathology
At necropsy, affected muscles appear pale pink to white with bilateral symmetry. Characteristic findings include white, chalky streaks or patches (dystrophic calcification) most prominent in cardiac muscle (especially left ventricle and interventricular septum) and postural skeletal muscles (tongue, neck, shoulder, gluteal, semimembranosus, semitendinosus). Intercostal and diaphragm muscles may also be affected. The tissue may feel dry and gritty due to calcium deposition.
Histopathology
Microscopic examination reveals polyphasic, polyfocal degeneration and necrosis of myofibers. Key histologic features include: hyaline degeneration (Zenker's necrosis) with swollen, hypereosinophilic, homogeneous sarcoplasm lacking cross-striations; floccular necrosis and myofiber fragmentation; loss of nuclei and sarcolemmal collapse; dystrophic mineralization/calcification of necrotic fibers; influx of macrophages and satellite cell proliferation (regeneration); and in chronic cases, fibrosis and evidence of regenerating myotubes with central nuclei and basophilic cytoplasm.
High-YieldThe term "polyphasic" indicates an ongoing degenerative process with lesions at different stages of necrosis and regeneration. This differentiates WMD from "monophasic" injuries like ionophore toxicity or capture myopathy where lesions are synchronous. On histology, polyphasic WMD shows necrotic, mineralizing, and regenerating fibers simultaneously.
Differential Diagnosis
| Differential |
Distinguishing Features |
| Capture Myopathy |
History of recent capture, handling, or transport stress; monophasic lesions; common in cervids |
| Ionophore Toxicity |
History of monensin/lasalocid exposure; monophasic; affects cardiac and skeletal muscle |
| Clostridial Myositis |
Asymmetric, localized swelling; gas, crepitus; severe toxemia; gram-positive rods on smear |
| Enterotoxemia |
Sudden death; pulpy kidney; may mimic cardiac WMD |
| Plant Toxicosis |
Cassia (coffee senna), white snakeroot; polyphasic pattern; history of access to toxic plants |
| Arthritis/Polyarthritis |
Joint swelling, heat, pain; fever; normal muscle enzymes unless secondary disuse |
| Copper Deficiency |
Camelids: ataxia, incoordination; similar geographic distribution; check Cu status |
Treatment
Acute Management
Treatment success depends on the form of disease and severity of muscle damage. The skeletal form responds favorably to treatment if initiated early, while the cardiac form is often refractory to therapy.
NAVLE TipSelenium toxicity has a narrow margin between therapeutic and toxic doses. Maximum total daily selenium consumption must not exceed 0.7 mg/head/day for sheep and similar-sized species. Signs of acute selenosis include garlic breath (from dimethyl selenide), incoordination, tachypnea, and sudden death. Chronic toxicity causes hair loss, hoof sloughing ("alkali disease"), and poor condition.
| Treatment |
Dosage |
Notes |
| Sodium Selenite + Vitamin E (Cattle/Sheep) |
1 mg Se + 50 mg (68 IU) Vit E per 18 kg (40 lb) SC or IM |
May repeat in 2 weeks; no more than 4 doses total |
| Camelids - Barium Selenate |
Depot SC injection (slow release over 12 months) |
AVOID sodium selenite/selenate (risk of acute hepatic failure) |
| Vitamin E (Oral) |
1,000-5,000 IU/day (large animals) |
Commercial Se/E products may lack therapeutic Vit E levels; supplement separately |
| Supportive Care |
IV fluids, anti-inflammatories, analgesics |
Limit physical activity; nutritional support via nasogastric tube if dysphagia |
| Antibiotics |
Broad-spectrum parenteral |
Prevent aspiration pneumonia if dysphagia present |
Prevention
Supplementation Strategies
| Method |
Details |
| Pregnant Dam Supplementation |
Selenium crosses placenta and is present in colostrum. Supplementing dams in late gestation prevents congenital WMD. Inject 4 weeks before parturition (cattle: 15 mg Se). |
| Neonatal Injection |
Prophylactic Se/Vit E at birth in endemic areas. Cervids: may be beneficial for neonatal calves. |
| Feed Supplementation |
FDA allows up to 0.3 ppm Se in complete rations (DM basis). Target 0.1-0.3 ppm total dietary Se. |
| Free-Choice Minerals |
Salt/mineral mixes at 90 ppm Se. Camelids: need product with 90 ppm Se if consuming 7-9 g/day to achieve 0.74 mg Se requirement. |
| Intraruminal Bolus |
Sustained-release bolus (50 mg Se) improves reproductive performance in sheep. |
| Soil Fertilization |
Application of 4 g Se/acre (10 g/hectare) in fertilizer. Used successfully in Finland. |
| Pasture/Forage Quality |
Fresh legumes and green pasture are good Vit E sources. Stored hay loses 50% Vit E per month. |